Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × peginterferon alfa-2a × Clear all

NCT02328755 2021-10-06

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

Phase 1/2 Completed

37 enrolled 20 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute